BioCentury
ARTICLE | Company News

BioLineRx, Bar Ilan University, Tel Aviv University deal

May 10, 2004 7:00 AM UTC

BioLineRx received exclusive worldwide rights to compounds that were developed by the universities to treat neurological diseases, including schizophrenia and cancer. The compounds are in research tes...